Nexium drives 7% Consumer growth at Pfizer

28 October 2015 - Deborah Wilkes

Archived

Pfizer said a 7% rise in worldwide sales by its Consumer Healthcare division in the third quarter of 2015 was primarily due to the performance of Nexium 24HR in the US.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: